Prevenire la morte improvvisa nel paziente uremico: mission impossible per cardionefrologi?

Nijpels G. , Heine R.J. , Bouter L.M. , Stehouwer C.D. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002; 62: 1402–07.

US Renal Data System Annual Data Report Bethesta, National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases, 2005.

Herzog C.A. , Mangrum J.M. , Passman R. Sudden cardiac death and dialysis patients. Semin Dial 2008; 21: 300–07.

Ritz E. , Strumpf C. , Katz F. , Wing A.J. , Quellhorst E. Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension 1985; 7: II118–II124.

Ganesh S.K. , Stack A.G. , Levin N.W. , Hulbert-Shearon T. , Port F.K. Association of elevated serum PO (4), CaPO (4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131–8.

Furgeson S.B. , Chonchol. Beta-blockade in chronic dialysis patients. Semin Dial 2008; 21: 43–8.

Karnik J.A. , Young B.S. , Lew N.L. , Herget M. , Dubinsky C. , Lazarus J.M. , Chertow G.M. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001; 60: 350–7.

Moss A.H. , Holley J.L. , Upton M.B. Outcomes of cardio-pulmonary resuscitation in dialysis patients. J Am Soc Nephrol 1992; 3: 1238–43.

Ranpuria R. , Hall M. , Chan C.T. , Unruh M. Heart rate variability (HRV) in kidney failure: measurement and consequences of reduced HRV. Nephrol Dial Transplant 2008; 23: 444–9.

Hayano J. , Takahashi H. , Toriyama T. , Mukai S. , Okada A. , Sakata S. , Yamada A. , Ohte N. , Kawahara H. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with endstage renal disease. Nephrol Dial Transplant 1999; 14: 1480–1488.

Wanner C. , Krane V. , März W. , Olschewski M. , Mann J.F. , Ruf G. , Ritz E. , German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238–248.

Ritz E. , Wanner C. : The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol 2008; 3: 920–929.

Remppis A. , Ritz E. : Cardiac problems in the dialysis patient: beyond coronary disease. Semin Dial 2008; 21: 319–325.

Saragoça M.A. , Canziani M.E. , Cassiolato J.L. , Gil M.A. , Andrade J.L. , Draibe S.A. , Martinez E.E. : Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients. J Cardiovasc Pharmacol 1991; 17(Suppl 2): S136–S138.

Parfrey P.S. , Foley R.N. , Harnett J.D. , Kent G.M. , Murray D.C. , Barre P.E. : Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277–1285.

Redaelli B. , Cavalli A. , Latini R: (No authors listed) Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients: Gruppo Emodialisi e Patologie Cardiovasculari. Lancet 1988; ii: 305–309.

Amann K. , Breitbach M. , Ritz E. , Mall G: Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998; 9: 1018–1022.

Bleyer A.J. , Hartman J. , Brannon P.C. , Reeves- Daniel A. , Satko S.G. , Russell G. : Characteristics of sudden death in hemodialysis patients. Kidney Int 2006; 69: 2268–2273.

Bleyer A.J. , Russell G.B. , Satko S.G. : Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999; 55: 1553–1559.

Kanbay M. , Afsar B. , Goldsmith D. , Covic A. Sudden death in hemodialysis: An Update. Blood Purif 2010; 30: 135–145.

Santoro A. , Mancini E. , London G. , Mercadal L. , Fessy H. , Perrone B. , Cagnoli L. , Grandi E. , Severi S. , Cavalcanti S. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal. Nephrol Dial Transplant. 2008 Apr; 23(4): 1415–21.

US Renal Data System: USRDS 2002 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002.

US Renal Data System: USRDS 2004 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004.

US Renal Data System: USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006

Cupisti A. , Gaietta F. , Caprioli R. , Morelli E. , Tintori G.C. , Franzoni F. , Lippi A. , Meola M. , Rindi P. , Barsotti G. : Potassium removal increases the QTc interval dispersion during hemodialysis. Nephron 1999; 82: 122–126.

Genovesi S. , Rivera R. , Fabbrini P. , Dossi C. , Bonforte G. , Mircoli L. , Ferrari A.U. , Stella A. , Stramba-Badiale M. : Dynamic QT interval analysis in uraemic patients receiving chronic haemodialysis. J Hypertens 2003; 21: 1921–1926.

Nakamura S. , Ogata C. , Aihara N. , Sasaki O. , Yoshihara F. , Nakahama H. , Inenaga T. , Kimura G. , Kawano Y. : QTc dispersion in haemodialysis patients with cardiac complications. Nephrology (Carlton) 2005; 10: 113–118.

Floccari F. , Aloisi E. , Nostro L. , Caccamo C. , Crisafulli A. , Barillà A. , Aloisi C. , Romeo A. , Corica F. , Ientile R. , Frisina N. , Buemi M. : QTc interval and QTc dispersion during haemodiafiltration. Nephrology (Carlton) 2004; 9: 335–340.

Herzog C.A. : Can we prevent sudden cardiac death in dialysis patients? Clin J Am Soc Nephrol 2007; 2: 410–412.

Rydén L. , Ariniego R. , Arnman K. , Herlitz J. , Hjalmarson A. , Holmberg S. , Reyes C. , Smedgârd P. , Svedberg K. , Vedin A. , Waagstein F. , Waldenström A. , Wilhelmsson C. , We-del H. , Yamamoto M. : A double-blind trial of metoprolol in acute myocardial infarction: effects on ventricular tachyarrhythmias. N Engl J Med 1983; 17; 308: 614–618.

Azevedo E.R. , Kubo T. , Mak S. , Al-Hesayen A. , Schofield A. , Allan R. , Kelly S. , Newton G.E. , Floras J.S. , Parker J.D. : Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation 2001; 104: 2194–2199.

Piccirillo G. , Luparini R.L. , Celli V. , Moisè A. , Lionetti M. , Marigliano V. , Cacciafesta M. : Effects of Carvedilol on heart rate and blood pressure variability in subjects with chronic heart failure. Am J Cardiol 2000; 86: 1392–1395, A6.

Mortara A. , La Rovere M.T. , Pinna G.D. , Maestri R. , Capomolla S. , Cobelli F. : Nonselective beta-adrenergic blocking agent, Carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol 2000; 36: 1612–1618.

Faber J.E. , Brody M.J. : Neural contribution to renal hypertension following acute renal artery stenosis in conscious rats. Hypertension 1983; 5: 1155–1164.

Ye S. , Ozgur B. , Campese V.M. : Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 1997; 51: 722–727.

Xu J. , Li G. , Wang P. , Velazquez H. , Yao X. , Li Y. , Wu Y. , Peixoto A. , Crowley S. , Desir G.V. : Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 2005; 115: 1275–1280.

Hausberg M. , Kosch M. , Harmelink P. , Barenbrock M. , Hohage H. , Kisters K. , Dietl K.H. , Rahn K.H. : Sympathetic nerve activity in end stage renal disease. Circulation 2002; 106: 1974–1979.

Daugirdas J.T. : Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001; 38(Suppl 4): S11–17.

Hjalmarson A. : Cardioprotection with betaadrenoceptor blockers: does lipophilicity matter? Basic Res Cardiol 2000; 95(Suppl 1): I41–I45.

Gehr T.W. , Tenero D.M. , Boyle D.A. , Qian Y. , Sica D.A. , Shusterman N.H. : The pharmacokinetics of Carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency. Eur J Clin Pharmacol 1999; 55: 269–277.

Feuerstein G.Z. , Hamburger S.A. , Smith EF 3rd , Bril A. , Ruffolo RR Jr. : Myocardial protection with Carvedilol. J Cardiovasc Pharmacol 1992; 19(Suppl 1): S138–S141.

Chonchol M. , Benderly M. , Goldbourt U. : Beta- blockers for coronary heart disease in chronic kidney disease. Nephrol Dial Transplant 2008; 23: 2274–2279.

Pun P.H. , Lehrich R.W. , Smith S.R. , Middleton J.P. : Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol 2007; 2: 491–500.

Cice G. , Ferrara L. , Di Benedetto A. , Russo P.E. , Marinelli G. , Pavese F. , Iacono A. : Dilated cardiomyopathy in dialysis patients - beneficial effects of Carvedilol: a double-blind, placebo- controlled trial. J Am Coll Cardiol 2001; 37: 407–411.

Cice G. , Ferrara L. , D'Andrea A. , D'Isa S. , Di Benedetto A. , Cittadini A. , Russo P.E. , Colino P. , Calabrò R. : Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol 2003; 41: 1438–1444.

Kalaitzidis R. , Bakris G. : Should nephrologists use beta-blockers? A perspective. Nephrol Dial Transplant 2009; 24: 701–702.

Efrati S. , Zaidenstein R. , Dishy V. , Beberashvili I. , Sharist M. , Averbukh Z. , Golik A. , Weissgarten J. : ACE inhibitors and survival of hemodialysis patients. Am J Kidney Dis 2002; 40: 1023–1029.

K/DOQI Workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45(Suppl 3): S1–S153.

Cice G , Di Benedetto A. , D'Isa S. , D'Andrea A. , Marcelli D. , Gatti E. , Calabrò R. , Effects of Telmisartan Added to Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Hemodialysis Patients With Chronic Heart Failure. A Double-Blind, Placebo-Controlled Trial. J Am Coll Cardiol 2010, 16: 1701–8.

Lehrich R.W. , Pun P.H. , Tanenbaum N.D. , Smith S.R. , Middleton J.P. : Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic. J Am Soc Nephrol 2007; 18: 312–320.

Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576–1583.

Hreybe H. , Ezzeddine R. , Bedi M. , Barrington W. , Bazaz R. , Ganz L.I. , Jain S. , Ngwu O. , London B. , Saba S. : Renal insufficiency predicts the time to first appropriate defibrillator shock. Am Heart J 2006; 151: 852–856.

Bloom H. , Heeke B. , Leon A. , Mera F. , Delurgio D. , Beshai J. , Langberg J. : Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006; 29: 142–145.

Bardy G.H. , Lee K.L. , Mark D.B. , Poole J.E. , Packer D.L. , Boineau R. , Domanski M. , Troutman C. , Anderson J. , Johnson G. , McNulty S.E. , Clapp-Channing N. , Davidson-Ray L.D. , Fraulo E.S. , Fishbein D.P. , Luceri R.M. , Ip J.H. , Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225–237.

Cuculich P.S. , Sánchez J.M. , Kerzner R. , Greenberg S.L. , Sengupta J. , Chen J. , Faddis M.N. , Gleva M.J. , Smith T.W. , Lindsay B.D. : Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 2007; 30: 207–213.

Moss A.J. , Zareba W. , Hall W.J. , Klein H. , Wilber D.J. , Cannom D.S. , Daubert J.P. , Higgins S.L. , Brown M.W. , Andrews M.L. , Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–883.

Eckart R.E. , Gula L.J. , Reynolds M.R. , Shry E.A. , Maisel W.H. : Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 2006; 17: 940–943.

Wase A. , Basit A. , Nazir R. , Jamal A. , Shah S. , Khan T. , Mohiuddin I. , White C. , Saklayen M. , McCullough P.A. : Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 2004; 11: 199–204.

Goldenberg I. , Moss A.J. , McNitt S. , Zareba W. , Andrews M.L. , Hall W.J. , Greenberg H. , Case R.B. ; Multicenter Automatic Defibrillator Implantation Trial-II Investigators: Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006; 98: 485–490.

McCullough P.A. : Why is chronic kidney disease the ‘spoiler’ for cardiovascular outcomes? J Am Coll Cardiol 2003; 41: 725–728.

Dasgupta A. , Montalvo J. , Medendorp S. , Lloyd-Jones D.M. , Ghossein C. , Goldberger J. , Passman R. : Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 2007; 49: 656–663.

Amin M.S. , Fox A.D. , Kalahasty G. , Shepard R.K. , Wood M.A. , Ellenbogen K.A. : Benefit of primary prevention implantable cardioverter- defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol 2008; 19: 1275–1280.

Robin J. , Weinberg K. , Tiongson J. , Carnethon M. , Reddy M. , Ciaccio C. , Quadrini M. , Hsu J. , Fan J. , Choi P. , Kadish A. , Goldberger J. , Passman R. : Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 2006; 3: 1196–1201.

Herzog C.A. , Li S. , Weinhandl E.D. , Strief J.W. , Collins A.J. , Gilbertson D.T. : Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005; 68: 818–825.